Join our daily newsletter At The Bell to receive exclusive market insights
- Antimicrobial solutions company Zoono Group (ZNO) has received regulatory approval for a number of its sanitiser products in Russia and the U.A.E.
- The company secured a five-year supply agreement and sizeable purchase order from hygiene suppliers in the UAE and Russia following the certifications
- Laboratory testing in Russia and Dubai was completed on ZNO’s surface and hand sanitisers to confirm its efficiencies in October this year
- ZNO also launched a face mask treated with Zoono sanitation technologies
- The company posted a revenue target of approximately $89 million over the next three years
- Zoono shares are up 4.26 per cent following the company’s general update, trading at $1.35
Antimicrobial solutions company Zoono Group (ZNO) has passed regulatory approval for a number of its sanitiser products in Russia and the U.A.E.
The company secured a five-year supply agreement and sizeable purchase order from hygiene suppliers in the UAE and Russia following the certifications.
Laboratory testing in Russia and Dubai was completed on ZNO’s surface and hand sanitisers to confirm its efficiencies in October this year.
Testing at Dubai Central Laboratory Department on Zoono Z-71 Microbe Shied Surface Sanitizer and Protectant found a 99.9 per cent reduction in bacteria found on material surfaces after 30 days.
Subsequently, Zoono’s Microbe Shield Surface received the Emirates Authority for Standardisation and Metrology (ESMA), the regulatory authority governing the certification of certain regulated products.
The five-year supply agreement with U.A.E. hygiene supplier Fine Hygienic Paper will grant Zoono access to the company’s network of 70 countries globally.
A company statement indicated Microbe Shield and Zoono Hand Alcohol-Free Sanitiser GermFree24 had also passed all local Russian laboratory testing.
Zoono secured its first purchase order from Russian-based ECO-SALUS for roughly $497,000 and an initial three-year term supply agreement.
ZNO also advised it would launch a triple-layered mask product treated with Zoono sanitation technologies, and the product is currently available for purchase.
The company posted a revenue target of approximately $89 million over the next three years.
Zoono shares are up 4.26 per cent following the company’s general update, trading at $1.35 at 11:39 am AEDT.
